Brainsway to showcase Deep TMS at APA Annual Meeting

BrainsWay (BWAY) announce its participation at the American Psychiatric Association Annual Meeting, taking place May 17-21, 2025, in Los Angeles, California. As part of the meeting’s educational programming, there will be a full day master course on Sunday, May 18, 2025, entitled: “Clinical Applications for Psychiatric Practice: Ketamine and TMS.” The course will provide an in-depth look at the integration of novel treatments into clinical psychiatric practice, highlighting practical approaches for improving patient outcomes through evidence-based, interventional psychiatry. It will feature several prominent clinician-researchers discussing innovative therapeutic approaches, including two presenters from BrainsWay, Dr. Richard Bermudes, the Company’s Chief Medical Officer and Dr. Colleen Hanlon, BrainsWay’s Vice President of Medical Affairs.